Literature DB >> 27830681

[Novel miRNA genes hypermethylated in breast cancer].

V I Loginov1,2, A M Burdennyy1, I V Pronina1, V V Khokonova1, S V Kurevljov1, T P Kazubskaya3, N E Kushlinskii3, E A Braga1,4.   

Abstract

MicroRNAs play an important role in the regulation of expression of many genes involved in cancer pathogenesis. One of the causes of miRNA level deregulation in tumors is the methylation of CpG islands in the promoter regions of the genes that encode them. Hypermethylation may lead to the suppression of miRNA gene expression and, as a consequence, to a decrease in their inhibitory effect on target gene mRNAs. A search for new miRNA genes hypermethylated in breast cancer has been carried out in the present study. The methylation of five miRNA genes associated with breast cancer (miR-132, miR-1258, miR-107, miR-130b, miR-137) has been as studied using a representative set of 41 breast cancer samples by methylation-specific PCR. Three new genes, MIR-132, MIR-137 and MIR-1258, with a high frequency of hypermethylation (41, 37 and 34%, respectively) have been identified in breast cancer. The methylation of these genes in the breast tissues of ten donors without cancer pathology in anamnesis was only found in single cases. These results enable the involvement of three miRNAs (miR-132, miR-137, miR-1258) and the methylation of the genes that encode them in the pathogenesis of breast cancer to be suggested.

Entities:  

Keywords:  breast cancer; hypermethylation; miRNA genes

Mesh:

Substances:

Year:  2016        PMID: 27830681     DOI: 10.7868/S0026898416050104

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  5 in total

1.  Synergy between the Levels of Methylation of microRNA Gene Sets in Primary Tumors and Metastases of Ovarian Cancer Patients.

Authors:  S S Lukina; A M Burdennyy; E A Filippova; I V Pronina; N A Ivanova; T P Kazubskaya; D N Kushlinskii; D O Utkin; V I Loginov; E A Braga; N E Kushlinskii
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

2.  Gga-miR-130b-3p inhibits MSB1 cell proliferation, migration, invasion, and its downregulation in MD tumor is attributed to hypermethylation.

Authors:  Chunfang Zhao; Xin Li; Bo Han; Lujiang Qu; Changjun Liu; Jiuzhou Song; Ling Lian; Ning Yang
Journal:  Oncotarget       Date:  2018-05-11

3.  Aberrant DNA methylation of miRNAs in Fuchs endothelial corneal dystrophy.

Authors:  Peipei Pan; Daniel J Weisenberger; Siyu Zheng; Marie Wolf; David G Hwang; Jennifer R Rose-Nussbaumer; Ula V Jurkunas; Matilda F Chan
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

4.  miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.

Authors:  Feiya Du; Ling Yu; Ying Wu; Shuqian Wang; Jia Yao; Xiaoxiao Zheng; Shangzhi Xie; Shufeng Zhang; Xuemei Lu; Yu Liu; Wei Chen
Journal:  Cell Death Dis       Date:  2019-12-04       Impact factor: 8.469

5.  MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.

Authors:  Sha Li; Jian-Jun Xu; Qing-Yun Zhang
Journal:  Cancer Sci       Date:  2019-08-19       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.